Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

ExsoMed Corporation Announces FDA 510(k) Clearance of 4 Corner Fusion System for Wrist Arthritis; Will Sell Asset to Stay Focused on Sterile-Packed, Single Use Business


News Image

ExsoMed’s Four Corner Fusion System

“ExsoMed’s Four Corner Fusion System brings an innovative problem-specific solution that offers the patient and the surgeon benefits beyond anything else in the market,” said Martin I. Boyer, MD, FRCS(C) of Washington University School of Medicine in Saint Louis, MO.

ExsoMed Corporation, a privately held U.S.-based medical device company providing orthopaedic surgeons with innovative solutions in hand surgery, received 510(k) clearance from the United States Food and Drug Administration for its Four Corner Fusion System to treat wrist arthritis.

Four Corner Fusion has shown to be a reliable option to treat wrist arthritis, however current product offerings still have many shortcomings, without much innovation being developed to address these issues. ExsoMed’s Four Corner Fusion System will provide surgeons with a solution that is simple to use, that requires less reaming, less “drill and fill”, no impingement on the lunate, and preserves the cartilage.

“I am pleased with the result of our work with ExsoMed,” said Martin I. Boyer, MD, FRCS(C) of Washington University School of Medicine in Saint Louis, MO. “This new Four Corner Fusion System brings an innovative problem-specific solution that offers the patient and the surgeon benefits beyond anything else in the market. Our system specifically preserves the articular cartilage of the proximal aspect of the lunate and corrects the capitolunate malalignment in both coronal and sagittal planes.”

In addition to Dr. Boyer, Kavi Sachar, MD of the Steadman Clinic in Vail, CO and Kathleen McKeon, MD of the Andrews Sports Medicine and Orthopaedic Center in Birmingham, AL were instrumental in the design of this product.

“ExsoMed is thrilled to have partnered with some of hand surgery’s brightest minds to develop this innovative Four Corner Fusion plating system,” said William E. Maya, ExsoMed’s Chief Executive Officer. “We believe the product brings significant advancement to what is often a difficult procedure with poor outcomes. The system is through the FDA clearance and patent processes; however, we have made a strategic business decision to stay focused on our market-differentiating, sterile-packed, single-use business model. ExsoMed will begin strategic discussions to sell this asset and ensure that it will be made available to enhance outcomes for surgeons and patients.”

For more information on ExsoMed’s Four Corner Fusion System, please contact James Kim at jkim@exsomed.com.

About ExsoMed

ExsoMed is a privately held medical device company providing orthopaedic surgeons with innovative solutions in hand surgery. We believe that our solutions raise the standard of care in hand surgery by providing state of the art surgical tools that streamline use in the operating room, reduce the global cost of care, and enhance outcomes so that patients can get back to life faster. For more information regarding ExsoMed, please visit http://www.exsomed.com.

“ExsoMed™ is a trademark of ExsoMed Corporation”

Share article on social media or email:

Eleven Health Departments Awarded Accreditation or Reaccreditation Status by the Public Health Accreditation Board


PHAB logo

“Accreditation is a tremendous milestone for our Tribal Health Center,” said Carrie Sampson-Samuels. “…after decades of addressing our unique health disparities with minimal funding and resources, we have strengthened our ability to protect and support our community’s health.”

The Public Health Accreditation Board (PHAB) today announced the names of eleven public health departments that have achieved accreditation or reaccreditation status, after completion of a systematic review process against national standards. These health departments have successfully demonstrated a commitment to a focus on accountability, equity and performance as they work to improve the health of their communities.

PHAB, the nongovernmental, nonprofit organization that administers the national accrediting program, works to improve and protect the health of the public by advancing and transforming the quality and performance of governmental public health departments in the United States and abroad.

“Now, more than ever, public health departments are relied upon to respond to emergencies like COVID-19 and extreme weather events, while at the same time preparing for flu season, providing timely and accurate data and information and enforcing regulations to keep people safe,” said Paul Kuehnert, President and CEO of PHAB. “We are proud of these health departments and the hundreds of others that are working tirelessly to provide critical services to their communities and have that work validated through a process as rigorous as ours.”

Serving the Confederated Tribes of the Umatilla Indian Reservation in Eastern Oregon, Yellowhawk Tribal Health Center becomes the fourth Tribal Health Department to achieve national accreditation through PHAB. “Accreditation is a tremendous milestone for our Tribal Health Center,” said Carrie Sampson-Samuels, Community Wellness Director. “We have demonstrated that after decades of addressing our unique health disparities with minimal funding and resources, we have strengthened our ability to protect and support our community’s health. Public health accreditation is an exercise of our inherent sovereignty as a tribal nation and we appreciate the support and consultation that PHAB has provided tribes to achieve this goal.”

In Oklahoma, Colonel Lance Frye, MD, State Commissioner of Health reflected on the importance of the state health department’s journey to become reaccredited. “I’m proud of the Department’s commitment to accountability and our focus on continuous performance and quality improvement. As we work to serve the nearly 4 million residents of Oklahoma, meeting national standards that demonstrate our commitment to them and our community, just makes good sense.”

PHAB, the nonprofit organization that administers the national public health accreditation program, aims to improve and protect the health of the public by advancing and transforming the quality and performance of governmental public health agencies in the U.S. and abroad. Launched in 2011 with support from the Centers for Disease Control and Prevention and the Robert Wood Johnson Foundation, PHAB’s accreditation program has become the national standard for public health in the United States.

National initial accreditation was awarded September 1, 2020 to:

  • Denton County Public Health, Denton, TX
  • Ontario County Public Health, Canandaigua, NY
  • Schuyler County Public Health, Watkins Glen, NY
  • Seneca County Health Department, Waterloo, NY
  • Steuben County Public Health, Bath, NY
  • Tulare County Health and Human Services Agency, Public Health Branch, Visalia, CA
  • Wayne County Public Health, Lyons, NY
  • Yates County Public Health, Penn Yan, NY
  • Yellowhawk Tribal Health Center, Pendleton, OR

National reaccreditation was awarded March 17, 2020 to:

  • Florida Department of Health, Tallahassee, FL
  • Oklahoma State Department of Health, Oklahoma City, FL

For more information, contact Jessica Solomon Fisher at jfisher@phaboard.org. Learn more about PHAB and accreditation at http://www.phaboard.org. Be in the know: subscribe to PHAB’s e-newsletter.

About the Public Health Accreditation Board

The Public Health Accreditation Board (PHAB) was created to serve as the national public health accrediting body and is funded in part by the Centers for Disease Control and Prevention and the Robert Wood Johnson Foundation. The development of national public health accreditation has involved, and is supported by, public health leaders and practitioners from the national, state, local, Tribal, and territorial levels.

Share article on social media or email:

Wana Brands and AltMed Florida Division Expand Partnership in Exclusive Deal to Bring America’s Favorite Edible to the Sunshine State


News Image

We know our Florida patients are always best served by the highest-quality products we can offer. Through this partnership with Wana Brands, we will have another quality alternative for our cannabis patients to experience.

With recently enacted rules for edible medical cannabis in Florida, Wana Brands and AltMed Florida announce an exclusive licensing agreement to allow AltMed Florida to produce and distribute Wana Edibles at MÜV™ Medical Cannabis Dispensaries (once approved by the Florida Department of Health’s Office of Medical Marijuana Use). AltMed Florida is one of the fastest-growing companies in the state, with 25 MÜV Dispensaries open now and 15 more in development throughout Florida.

“Through our partnership with AltMed Florida, Wana Brands will now be able to offer Floridians an alternative form of cannabis consumption that can better fit their health needs,” said Nancy Whiteman, CEO, Wana Brands. “This proven partnership helped to build Wana into the No. 1 selling edible in Arizona and looks to do the same in Florida through the AltMed Florida division.”

The partnership between Wana Brands, an industry leader in cannabis-infused products and the No. 1 edibles brand in the United States, and AltMed Florida, a vertically integrated cannabis company with a state-of-the-art indoor cultivation facility in Apollo Beach, is one centered on a mutual attention to quality products and services.

Illustrating this is how Wana’s cannabis-infused products are consistently judged to be best-in-class in multiple and year-over-year evaluations by media and industry observers. AltMed Florida, which has a mission to provide the highest quality and variety of cannabis products to its patients, was recently awarded the 2019 Leafbuyer Award for Best Product Selection in a Florida Cannabis Dispensary.

“We know our Florida patients are always best served by the highest-quality products we can offer,” said John Tipton, CEO of AltMed Florida. “Through this partnership with Wana Brands, we will have another quality alternative for our cannabis patients to experience.”

This partnership will bring Wana, America’s number one edible brand, exclusively to MÜV Medical Cannabis Dispensaries making it available to the more than 409,000 active patients in Florida.

Wana Brands’ products are held to the strictest quality standards. All of Wana’s products have undergone rigorous third-party testing since the company was launched in 2010. Wana Edibles are expected be on MÜV Medical Cannabis Dispensary shelves later this year, pending all required approvals from the Florida Department of Health’s Office of Medical Marijuana Use.

Wana Brands: Enhance Your Life.

Included in the 2020 Inc. 5000 list at #2,074 and boasting a three-year growth rate of 203%, Wana Brands is the No. 1 edibles brand in the United States, with more dollars sold than any other brand, according to BDS Analytics 2019 Brand Share Report. Wana leads the industry in quality, consistency and potency, providing a range of different options that enable customers to create the specific cannabis experience they want. Wana products offer diverse product forms including edibles, vapes, and extended-release capsules, four different CBD/THC ratios as well as a variety of different dosages, onset times and duration of effects. The portfolio is designed so products can be used singly or in combination to address specific health, wellness, and recreational needs. Wana products are available in Colorado, California, Illinois, Maryland, Michigan, Ohio, Arizona, Oregon and Oklahoma dispensaries, with Missouri and Florida (as regulations allow) among the states imminently coming online. Wana Brands is also available internationally in Canada. For more information or to subscribe to Wana’s e-newsletter, visit http://www.wanabrands.com.

About Plants of Ruskin, LLC – d.b.a. AltMed Florida, LLC – With a focus on quality and attention to detail, Plants of Ruskin has more than 35 years of experience in providing seedlings to farmers for vegetable and medical product production. Plants of Ruskin founders, the Dickman Family, are 4th generation farmers with a long history of working in conjunction with the University of Florida, including an endowed chair specifically dedicated to plant improvement.

AltMed Enterprises

Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated company that brings pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.

MÜV™ – The MÜV brand of cannabis infused products was launched in Arizona in 2016 and quickly gained international attention and recognition. In its first six months alone, MÜV received four best of Arizona medical cannabis awards, including two first prizes for its proprietary Ethanol extractions that are the basis of all MÜV products.

Share article on social media or email:

DPHARM Presents the Largest Number of Sessions Across R&D on Decentralized Clinical Trials Due to COVID-19, Presented by The Conference Forum


DPHARM’s strong growth over the past 10 years is due to its commitment to a patient-centered vision that resonates with R&D leaders, who are united in the shared goal of increasing virtual and flexible trial options for patients.

The Conference Forum’s DPHARM event, the world’s leading conference on decentralized clinical trials, today announced that it has received a record number of speaking submissions across the pharmaceutical industry to present on the rapid deployment of decentralized clinical trials at the 10th annual event, to be held virtually on September 22-23.

DPHARM will feature more than 20 talks from pharma companies, which will share learnings from decentralizing clinical trials during the COVID pandemic, with representation from EMD Serono, Janssen, Pfizer, Novartis, GSK, BMS, Roche, Sanofi, Eli Lilly, Takeda, Boehringer Inghelheim UCB, Vertex, BMS, Regeneron and more. Leading CROs and tech, software and service companies that have been on the front lines partnering to rapidly decentralize clinical trial technologies and services will also be speaking. These include IQVIA, Parexel, PRA Health, Oracle Health Sciences, Microsoft, TrialSpark, Science37, Trialscope, Edetek, Thread, Saama, Tasso, BBK and Elligo to name a few.

“We are especially delighted to welcome Amy Abernerthy, MD, PhD, Principal Deputy Commissioner of the FDA and one of the leading voices on modernizing clinical trials, to speak on decentralized clinical trials as well as real world data, technology and patient centrality”, said Valerie Bowling, DPHARM Director.

DPHARM’s strong growth over the past 10 years is due to its commitment to a patient-centered vision that resonates with R&D leaders, who are united in the shared goal of increasing virtual and flexible trial options for patients. DPHARM’s additional achievements include:


  • 300% growth in total attendance since launch
  • 5X growth in speaking faculty since launch
  • The most keynote-level speakers for a decentralized clinical trial-focused event
  • One of the first R&D conferences to include patient perspectives
  • The formation of DPHARM Idol which highlights young entrepreneurial companies demonstrating their ability to disrupt an aspect of clinical trials
  • DPHARM-launched sister events to help reduce the gaps between care, industry and patients, including Patients as Partners, Mobile in Clinical Trials and CRAACO: Clinical – Research as a Care Option
  • Technology sessions focused on solving industry issues
  • A dedicated quarterly DPHARM newsletter highlighting voices from all sides of R&D committed to bold ideas to reduce barriers for patients to participate in clinical research

About DPHARM

DPHARM is the first conference solely dedicated to challenging and reporting on innovation to modernize clinical trials. DPHARM has been featuring examples of disruptive innovation for 10 years to leaders in the pharmaceutical and biotech industry with the aim of reducing the barriers of participation for patients and expanding the diversity of representation. DPHARM will take place September 22-23 virtually. Learn more here.

Share article on social media or email:

Christina Sommerfield is Griswold Home Care’s New Vice President of…


Griswold Home Care's Vice President of Company Owned Offices position demonstrates the home care company’s commitment to growing its company owned offices, scattered throughout Pennsylvania,…

(PRWeb September 09, 2020)

Read the full story at https://www.prweb.com/releases/christina_sommerfield_is_griswold_home_cares_new_vice_president_of_company_owned_offices/prweb17380522.htm

Top Certified Emergency and Pediatric Emergency Nurses Honored With BCEN 2020 Distinguished Awards


BCEN honors one top Certified Emergency Nurse and one top Certified Pediatric Emergency Nurse with its annual national Distinguished CEN and CPEN Awards.

“In a year when the value and impact of nurses and emergency nursing expertise are front and center on the world stage, BCEN celebrates the extraordinary and inspirational ways Jude Lark and Lisa Chambers work to ensure emergency patients of every age receive the best possible nursing care.”

The Board of Certification for Emergency Nursing (BCEN), the benchmark for board certification across the emergency nursing spectrum, today recognized two outstanding emergency nurses with its 2020 Distinguished CEN and Distinguished CPEN Awards. These annual national awards recognize one board certified emergency nurse and one board certified pediatric emergency nurse from among nearly 40,000 Certified Emergency Nurses (CENs) and over 5,200 Certified Pediatric Emergency Nurses (CPENs), respectively.


  • BCEN’s 2020 Distinguished CEN Award winner is Jude Lark, BSN, RN, CEN, CCRN, emergency services clinical nurse educator at Atlantic Health System’s Overlook Medical Center in Summit, New Jersey.
  • BCEN’s 2020 Distinguished CPEN Award winner is Lisa Chambers, MSN, MPS, RN, CEN, CPEN, TCRN, emergency services/trauma clinical educator and clinical nurse III at CHOC Children’s Hospital in Orange, California.

“In a year when the value and impact of nurses and emergency nursing expertise are front and center on the world stage, BCEN celebrates the extraordinary and inspirational ways Jude Lark and Lisa Chambers work to ensure emergency patients of every age receive the best possible nursing care,” said BCEN Executive Director Janie Schumaker, MBA, BSN, RN, CEN, CENP, CPHQ, FABC.

BCEN’s Distinguished Awards recognize one top nurse in each emergency nursing specialty who demonstrates clinical and professional excellence while supporting and advocating for others to earn their specialty board credentials. Nurses who earn the CEN and CPEN designations have demonstrated advanced knowledge, expertise and clinical judgment in the mixed/adult and pediatric emergency specialties, respectively.

Lark and Chambers talked with BCEN about their award-winning work and the importance of certified emergency nursing excellence in their “Meet the Winner” Q&As here: CEN winner and CPEN winner.

The chief nursing officers at Overlook and CHOC Children’s had this to say about their award winners:

  • “There is no greater champion for the certification and training of emergency nurses at Overlook than Jude Lark. From the moment our nurses join us at orientation, Jude sets the goal for them to attain their CEN within a year, and then works diligently to help them achieve it. She developed and facilitated Atlantic Health System’s first ED residency program across six campuses this year, even as the COVID-19 pandemic arose in our communities and impacted our hospitals,” said MaryPat Sullivan, MSN, RN, CNS, chief nursing officer for Overlook Medical Center. “She is the consummate emergency department nurse—proficient, professional and compassionate—and is highly deserving of this national recognition.”
  • “Lisa Chambers is one of CHOC Children’s finest. As an emergency department clinical educator, she passionately guides frontline staff in integrating knowledge, skill, and behaviors to improve nursing practice and patient care,” said Melanie Patterson, DNP, MHA, RN, vice president, patient care services, and chief nursing officer, CHOC Children’s. “Lisa is a role model who promotes quality, compassion and inquisitive thinking. We applaud her for this well-deserved distinction.”

When asked what receiving the BCEN Distinguished Award means to them, the honorees said:

  • “This award brings to light all the resilient and very capable certified nurses that we have developed here at the Overlook ED. Over the past six years, we have increased our certified nurses by 52%. It has made an impact, and I have seen that,” said Distinguished CEN honoree Lark. “I have always thought that certification represents excellence in your field. I am so honored and extremely proud. I just hope every single day that I can make a difference in one of the team members I work with.”
  • “I am very humbled and also know there are many other deserving nurses who recognize the importance of being certified and continue to push their colleagues to succeed and exceed their own dreams,” said Distinguished CPEN honoree Chambers. “When you are CPEN-certified, you know you have the knowledge necessary to provide the best care for kids no matter where you work. Hopefully, more emergency nurses will be inspired to move forward and be encouraged that they can do this. And do it for the kids.”

About BCEN’s Annual Nurse and Organizational Awards

Every year, BCEN recognizes individual specialty certified emergency, trauma and transport nurses as well as healthcare facilities and health systems that demonstrate and advance certified nursing excellence and advocate for emergency nurse board certification. Learn more about BCEN’s Distinguished Awards and National Certification Champion Awards at bcen.org/awards.

About BCEN

Throughout 2020, the independent, not-for-profit Board of Certification for Emergency Nursing (BCEN®) is celebrating 40 years of robust certification programs fostering empowered nurses across the emergency spectrum who contribute noticeably to patient care, safety and outcomes. Over 55,000 BCEN board certifications are currently held by registered nurses (RNs) who specialize in emergency, flight, critical care ground transport, pediatric emergency and trauma nursing. BCEN offers the Certified Emergency Nurse (CEN®), Certified Flight Registered Nurse (CFRN®), Certified Pediatric Emergency Nurse (CPEN®), Certified Transport Registered Nurse (CTRN®) and Trauma Certified Registered Nurse (TCRN®) certifications. The CEN, CFRN, CPEN, and TCRN certification programs are accredited by the Accreditation Board for Specialty Nursing Certification (ABSNC). Learn more at bcen.org. Follow BCEN on Facebook, LinkedIn and Instagram.

# # #

Note to Editors: Photos of Lark and Chambers are available by request.

Share article on social media or email:

Catalent Invests $130 Million to Add Additional Manufacturing Capacity at its Gene Therapy Campus in Harmans, Maryland


It is critical that we stay connected to the needs of our customers as they progress through the clinical pipeline.

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it is investing $130 million to add five additional Phase 3 through commercial-scale manufacturing suites to its gene therapy campus in Harmans, Maryland to support a growing customer pipeline and market demand.

The Catalent Gene Therapy campus in Harmans, near the Baltimore Washington International (BWI) airport, comprises two state-of-the-art facilities that, when completed, will house a total of 15 gene therapy suites each designed to accommodate multiple bioreactors for commercial supply. The first Harmans/BWI facility on the campus was recently approved by the FDA for commercial manufacturing and is expected to have all 10 cGMP suites qualified and operational by the first quarter of 2021. The five new cGMP suites will be located in an adjacent building on the Harmans campus and are anticipated to be operational in the first half of 2022. The second Harmans building will also offer cold storage warehousing and additional office space.

“It is critical that we stay connected to the needs of our customers as they progress through the clinical pipeline. By increasing our late-stage manufacturing capacity at the Harmans campus, we will be able to meet demand through the medium term and take advantage of our shared resources, including the technical and manufacturing expertise that helped us reach the milestone of becoming an FDA-approved commercial partner,” commented Manja Boerman, Ph.D., President, Cell & Gene Therapy at Catalent. “Catalent is committed to this journey with our customers as they bring life-changing therapies to their patients.”

Catalent’s state-of-the-art Harmans/BWI commercial manufacturing campus is equipped with single-use manufacturing technology, and currently includes over 200,000 square feet (18,600 square meters) of late-stage clinical and commercial-stage gene therapy production. Upon outfitting of the second building, the large-scale Harmans/BWI production campus will encompass a total footprint of approximately 350,000 square feet. The campus is one of Catalent’s five gene therapy locations in Maryland and houses multiple cGMP manufacturing suites with pre-seed, bioreactor, and downstream rooms, together with fill/finish, testing, warehousing, supply chain, and central services capabilities.

About Catalent Cell & Gene Therapy

With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,900 people, including approximately 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Paul Newman’s Hole in the Wall Gang Camp Fandango Benefit Gala Goes Virtual with Campers and Celebrities Celebrating a 30-Year Tradition of Hope and Healing


Camp Is Everywhere: A Hole in the Wall Celebration of Hope and Healing will stream Sunday, September 13, 2020 at 7 p.m. ET on The Hole in the Wall Gang Camp’s website, Facebook and YouTube.

Soon after Paul Newman founded The Hole in the Wall Gang Camp in 1988, he knew the organization needed an annual event to raise funds for its programs serving seriously ill children and their families. Wanting it to be different than any other fundraiser, in 1990 he staged an entertaining variety show in the Camp’s theater featuring inspirational campers performing alongside celebrity friends. It became known as the Fandango Benefit Gala. And during a pandemic when the Camp has shifted all of its in-person programs to alternative and virtual expressions, its 30th gala is following suit as Camp Is Everywhere: A Hole in the Wall Celebration of Hope and Healing streams for free at http://www.holeinthewallgang.org/campiseverywhere on Sunday, September 13th at 7 PM ET.

“Even though we all can’t be together at Camp for the Gala this year, it is important to keep the tradition going and remind Hole in the Wall’s community of supporters that Camp is everywhere,” said CEO Jimmy Canton. “We also hope that this year’s virtual celebration will allow us to share the magic of Hole in the Wall with some new friends at a time when the world needs more hope and healing.”

Before Newman passed away in 2008, he and author A.E. Hotchner were steadily at the helm of the annual Fandango with Hotchner writing hilarious skits and parodies of musicals that always put Newman in self-deprecating roles. In addition to performing alongside the campers, Newman also invited a who’s who of Hollywood and Broadway stars to join him each year including Alec Baldwin, Harry Belafonte, Whoopi Goldberg, Bernadette Peters, Chita Rivera, Julia Roberts, Jerry Seinfeld, Meryl Streep and Robin Williams. No red carpets. No press. The casual event was all about bringing donors to Camp for a festive day in support of the children and their families. In recent years, a mix of old and new celebrity friends have continued to carry Newman’s Gala torch and this year the six camper performers will be joined by Stephen Colbert, Dane DeHaan, Jonathan Groff, Melissa Joan Hart, Ethan Hawke, Tyler Hoechlin, John Lithgow, Aasif Mandvi, Bridget Moynahan, Steven Pasquale, Rhonda Ross, Luke Wilson, Anna Wood and other surprise guests. Carole King, who appeared in several Hole in the Wall Galas, will perform a tribute to Hotchner, a founding Camp board member who died earlier this year at age 102.

About The Hole in the Wall Gang Camp

Founded in 1988 by Paul Newman, The Hole in the Wall Gang Camp provides “a different kind of healing” to more than 20,000 seriously ill children and family members annually – all completely free of charge. For many of these children and families, Hole in the Wall provides multiple Camp experiences throughout the year at the facility in Ashford, Conn., in more than 40 hospitals and clinics, directly in camper homes and communities, and through other outreach activities across the Northeast and mid-Atlantic. Learn more at http://www.holeinthewallgang.org.

###

Share article on social media or email:

Mytonomy Enters Behavioral Health Space with Enterprise Virtual Care Offering


Mytonomy, a digital health company that enables asynchronous virtual care, announced today a comprehensive set of over 75 new enterprise behavioral health microlearning videos to deliver remote behavioral health services in digital health platforms and clinics. During a time of intense demand for behavioral health services, this offering will address the most pressing needs emerging during COVID-19, such as coping with isolation, depression, anxiety, overall mental health and wellness, as well as substance abuse, pain management, preventing opioid addiction, postpartum depression, and anxiety.

“There has been a significant uptick in folks struggling with serious behavioral health problems, but not everyone is able to access one-on-one treatment,” said Dr. Robert Trestman, chair of psychiatry at Carilion Clinic, chair of the American Psychiatric Association’s Council on Healthcare Systems and Financing and chair-elect of the American Hospital Association’s Behavioral Health Council. “The Centers for Disease Control and Prevention (CDC) just completed a nationwide survey on the emotional and behavioral consequences of COVID-19. Overall, 41 percent reported significant psychiatric symptoms including anxiety or depression (31 percent), trauma and stress related symptoms (26 percent), started or worsened substance misuse (13 percent), and serious consideration of suicide (11 percent). With Mytonomy, we’re able to provide the essential information patients need to keep themselves and their families safe and well, within the comfort of their homes, allowing them to learn about their conditions and self-manage some of those symptoms while they wait to see a professional, either in person or through a telehealth mental health appointment.”

Market research indicates that a majority of behavioral health care services will migrate to virtual in the next 20 years, a shift Mytonomy is at the forefront of, combining existing models in new ways. By bringing together the best of enterprise SaaS, consumer tech, high-touch customer experience, with powerful analytics and award-winning short films, Mytonomy’s Patient Experience Cloud™ offers a differentiated approach to patient engagement.

“The number one request we have been receiving from providers and employers during this pandemic is for behavioral health content, and we are thrilled to be able to meet this rapidly growing need with an innovative approach that is tailored to patients. With behavioral health treatment, people often feel alone, isolated, and perhaps at times embarrassed or ashamed to seek help, and Mytonomy is giving them a private access to self-care on a wide range of behavioral health topics such as improving mood, developing resilience, managing and recognizing anxiety from the comfort of their living room,” said Anjali Kataria, CEO and co-founder of Mytonomy. “Our entry into behavioral health is a testament to the power and flexibility of Mytonomy’s virtual care platform, which is increasingly critical to health systems and remote patient monitoring clinics as they rely on Mytonomy’s content and platform to help them deliver care more efficiently via new virtual care models.”

Mytonomy has quickly become a major player in large-scale virtual health patient engagement and education. The company leverages a master content management solution at the heart of their novel CRM platform to deliver a digital front door to healthcare, helping clinicians and coaches deliver care to patients virtually, asynchronously and subsequently helping patients actively care for themselves in between and after their appointments from the comfort of their living room. Drawing from a library of over 1,500 peer-reviewed, clinically accurate microlearning videos originally produced in Mytonomy’s in-house studio, and combined with provider-specific content, Mytonomy is able to deliver a novel digital patient engagement strategy that saves time and reduces cost while improving quality of care.

“Behavioral health issues often afflict our patients with diabetes and other cardio-metabolic conditions, such as hypertension and hyperlipidemia, and can often impact the care of those conditions. The pandemic exacerbated the issues of isolation, anxiety, and other mental health conditions – so more than ever, we need a solution to help our patients,” said Dr. Christopher Cannon, Director, Education, Cardiovascular Medicine Innovation at Brigham and Women’s Hospital, a leading remote patient monitoring clinic. “Mytonomy is providing the critical digital health infrastructure and high production value video content that we need to reach patients at home, and engage them, when it’s harder and harder to access care – and they do this really well.”

Mytonomy has a strong track record of reaching broad, diverse audiences and improving relationships between patients and clinicians across multiple conditions, ranging from cardiometabolic to labor and delivery to surgery. Future releases in behavioral health will include sleep and sleep habits, opioid addiction and recovery, chronic pain management, smoking cessation and deeper coverage in depression and anxiety.

Recently, Mytonomy was awarded 19 Telly Awards for originally produced videos, ranked on the Inc. 5000 list of the fastest growing private companies in the nation, and named one of the top digital health companies by the UCSF Digital Health Awards.

About Mytonomy

Mytonomy is a digital health company with a singular mission: empower people to become confident and active participants in their health. Being diagnosed with a health condition and navigating the health system is stressful and confusing, driving people to piece things together through a web search, friends, and social media. Mytonomy’s Patient Experience Cloud™ enables health systems and remote patient monitoring clinics to deliver virtual care more efficiently, using award-winning, clinically accurate, peer-reviewed microlearning video content delivered through an easy-to-use enterprise digital platform. Mytonomy delivers cost savings to health care providers via a combination of master content management, data analytics, and real time feedback to create a hybrid digital-human interaction carrying patients through a seamless patient journey from patient/coach or patient/clinician into a digital world allowing for an overall improved experience for both the patient and the provider. Mytonomy’s platform seamlessly integrates with partner solutions, such as digital health platforms and remote clinics, with custom APIs. This enables patients to readily understand and access the information they need to care for themselves safely and securely, whenever and wherever it’s convenient for them to start living a healthier, happier life. With people spending an average of 30-40 minutes viewing Mytonomy’s short-form video content, on any device, at any time, they learn how to care for themselves and take charge of their health, achieving better outcomes. Providers save valuable time and generate better financial results across multiple patient encounters. Mytonomy is like a “Netflix for healthcare,” enabling healthcare’s digital front door. To learn more about Mytonomy, visit: https://www.mytonomy.com/

###

Share article on social media or email:

A Virtual Summit Celebrating the Frontier of Biology & Engineering


News Image

Today, Petri, an early-stage venture capital firm that develops companies at the intersection of biology and engineering, announced the company will be hosting The Dish, a one-day virtual summit that celebrates the field of bioengineering. The Dish will bring together industry thought leaders and the next generation of founders creating and scaling companies in this growing industry. The Dish will introduce Petri’s first class of companies, a diverse group solving problems across many areas including medicine, materials, food & agriculture, and research tools. The Dish will take place virtually on Wednesday, September 16th from 12:00pm – 2:30pm ET. Industry professionals, entrepreneurs, investors, media, and academics are all encouraged to attend.

The Dish will feature industry thought leaders such as George Church, Daphne Koller, and Stan Lapidus, among many others across the Petri network. Topics of keynotes, panels, and fireside chats during The Dish include the future of agriculture and food, new therapeutic modalities and business models, and unexplored topics in COVID-19. The Dish will also host virtual networking opportunities so those working in the bioengineering ecosystem can connect for the greater success of the field.

As part of The Dish, Petri will introduce the founders of its first class of companies. Founders speaking at the summit include: Mimoun Cadosch Delmar (Matterworks), Luciano Bueno (GALY), Virginia Burger (New Equilibrium Biosciences), Mike Koeris (Vulcan Biologics), Rayees Rahman (AIchemy), Nikin Tharan (Medsix), and Sam Rodriques (Petri Entrepreneur in Residence, Helios).

“We are proud to introduce many of our founders at The Dish. Many began working with us prior to incorporation, and since then have achieved technical proofs of concept, added key senior team members, won global accolades, and raised several million in follow-on capital, all hardwon under extraordinary circumstances,” said Tony Kulesa of Petri.

More about Petri’s first class of companies and the founders behind them:

AIchemy is a drug discovery company that leverages AI and kinase biology expertise to develop next generation small molecule drugs for cancer. Founded by Dr. Rayees Rahman, Prof. Avner Schlessinger, and Dr. Jason Lee.

GALY is producing lab-grown cotton, using a proprietary process that is 10x faster, requires 78% less water, 81% less land and 80% fewer gas emissions, with superior quality and cheaper than Egyptian cotton. Founded by Luciano Bueno and Dr. Paula Elbl.

Medsix is building novel wound drainage monitoring sensors and predictive tools for better patient outcomes. Founded by Nikin Tharan, Geoff Bocobo, Dr. Indraneil Mukherjee, Dr. Niloy Choudhury.

New Equilibrium Biosciences is creating therapeutics that target intrinsically disordered proteins, a class of currently undrugged proteins implicated in most cancers and neurodegenerative disorders, through its AI-biophysics-powered platform. Founded by Dr. Virginia Burger and Prof. Peter Tompa.

Vulcan Biologics is creating next generation synthetic biology phage-based therapeutics. Founded by Prof. Mike Koeris and Prof. Tim Lu.

Matterworks is building new phenotyping tools for biotechnology. Founded by Mimoun Cadosch Delmar.

A stealth company in synthetic biology founded by Prof. George Church and a Church Lab doctoral student.

A stealth company in therapeutics and gastrointestinal medicine.

For more information about The Dish and to register for the event, please visit:

https://www.petri.bio/thedish

About Petri:

Launched in fall of 2019, Petri is an early-stage venture capital firm dedicated to developing companies at the frontier of biology and engineering, co-created with Pillar VC and industry stars including Brian Baynes (serial entrepreneur and investor), Reshma Shetty (Ginkgo Bioworks), Emily Leproust (Twist Bioscience), Stan Lapidus (Exact Sciences, Cytyc), Daphne Koller (Insitro), Alec Nielsen (Asimov), Andy Beck (PathAI), JP Mangeolle (Danaher, Sciex, Phenomenex), Bernhard van Lengerich (General Mills, Beyond Meat), and leading researchers Chris Voigt, Pam Silver, and George Church. Petri supports early-stage founders to bring innovation out of the lab by investing pre-seed and seed capital, providing strategic guidance, and offering curated access to a network of 200+ seasoned mentors, talent from top universities, and 250+ investors and strategic partners.

To find out more about Petri please visit: http://www.petri.bio.

Share article on social media or email: